Sanofi Proposes Appointment of New Independent Directors
By Nina Kienle
Sanofi said it would propose the appointment of new independent directors, as Diane Souza, and Thomas Suedhof intend to leave at the end of their second terms.
The French pharmaceutical company said late Thursday that it plans to propose the appointment of Clotilde Delbos, Anne-Francoise Nesmes and John Sundy as independent directors as well as the renewal of the terms of office of Rachel Duan and Lise Kingo.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
February 23, 2024 04:59 ET (09:59 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing